Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;11(22):4182-4192.
doi: 10.1002/cam4.4770. Epub 2022 Apr 24.

Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients

Yuan Jian  1 , Huixing Zhou  1 , Yidan Wang  2 , Zhiyao Zhang  1 , Guangzhong Yang  1 , Chuanying Geng  1 , Ying Tian  1 , Wen Gao  1 , Wenming Chen  1
Affiliations

Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients

Yuan Jian et al. Cancer Med. 2022 Nov.

Abstract

Background: Pulmonary hypertension (PH) is a common but rarely recognized comorbidity of multiple myeloma (MM) patients, while its prognostic significance for MM has been rarely reported.

Methods: We retrospectively analyzed the clinical characteristics and prognostic value of baseline echocardiography-defined PH in 426 newly diagnosed MM (NDMM) patients.

Results: Echocardiograph-defined PH was found in 12.7% (54/426) of NDMM patients, associated with older age, anemia, and renal insufficiency, as well as severe diastolic dysfunction and higher BNP and NT-pro-BNP levels. Patients with PH presented with a higher prevalence of atrial fibrillation, while with a similar incidence of thrombosis compared with those without PH. Based on similar treatment regimens and autologous stem cell transplantation (ASCT) rates, patients without PH have deeper and better responses than those with PH (p = 0.002). With the remission of MM, 81.5% of PH was reversible, accompanied by improvement of right ventricular dysfunction and normalization of BNP/NT-pro-BNP levels, while could reoccur at MM relapse. Survival analysis revealed that PH was an adverse prognostic factor, associated with reduced progression-free survival (PFS) (21 vs. 50 months, p < 0.001) and overall survival (OS) (45 vs. 90 months, p = 0.014). Multivariate analysis further verified that baseline PH was an independent predictor for shorter PFS and OS.

Conclusion: In conclusion, echocardiography-defined PH is an adverse prognostic indicator for MM patients and should be routinely evaluated in MM patients at diagnosis to make a precise prognosis.

Keywords: echocardiography; multiple myeloma; prognosis; pulmonary hypertension; survival.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Pulmonary arterial pressures (PAPs) on different disease statuses
FIGURE 2
FIGURE 2
Effects of PH on progression‐free (PFS) (A) and overall survival (OS) (B)
See this image and copyright information in PMC

References

    1. Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management. Am J Hematol. 2020;95(5):548‐567. - PubMed
    1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046‐1060. - PubMed
    1. Kistler KD, Rajangam K, Faich G, Lanes S. Cardiac event rates in patients with newly diagnosed and relapsed multiple myeloma in US clinical practice. Blood. 2012;120(21):2916.
    1. Patel VG, Cornell RF. Cardiovascular complications associated with multiple myeloma therapies: incidence, pathophysiology, and management. Curr Oncol Rep. 2019;21(4):29. - PubMed
    1. Hirani N, Brunner NW, Kapasi A, et al. Canadian cardiovascular society/Canadian thoracic society position statement on pulmonary hypertension. Can J Cardiol. 2020;36(7):977‐992. - PubMed

Publication types

MeSH terms